TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Assessment of adverse events (AEs) and treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Injection site safety and tolerability assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical laboratory measurements - Hematology - hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Effect of web-based training
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Recurrent retinal detachment (RD)
Endpoint domain: Mortality/survival
Primary endpoint: Complete response (CR) rate at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial response (PR) rate at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the concentrations of blood metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in the concentrations of blood mRNA transcripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Informed choice
Endpoint domain: Life impact
Endpoint subdomain: Decision-making
Primary endpoint: Physiological Relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Function Measures (MFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myogrip/Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myopinch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACTIVLIM Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes on the Fugl-Meyer test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of functional navigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of location of cortical hand/leg motor area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appetite change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of self-reported exercise snack breaks at work
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in The Fugl-Meyer Assessment (FMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported smoking cessation verified by expired-air Carbon Monoxide (CO) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total score of CAPS-5
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to first AF event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in AF burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: AUClast of JLP-2002
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of JLP-2002
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral phase of swallow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pharyngeal phase of swallow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain imaging computed tomography CT or magnetic resonance imaging MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Cognitive Function Change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: External rotation of the shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net adverse clinical cardiovascular events (NACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Coronary Artery Disease Education Questionnaire (CADEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Regenerated Bone Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in The Box and Block Test (BBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in The Nine-Hole Peg Test (NHPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to start flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Severity of the edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tinnitus Functional Index score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of neuromuscular block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Calgary Depression Rating Scale (CDRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive and Negative Symptom Rating Scale (PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dietary usability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Usefulness of imaging for biopsies and/or ablations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPP-4 level detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Bilateral node detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Synaptic Vesicular Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma goserelin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: The Jamar Hydraulic Hand Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease rate of Lymphocyte
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ratio of 1-year resting PVR to baseline resting PVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LUS score preop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LUS score postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility and Balance Score (MBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Umbilical cord infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Patency rate (Absence of clinically driven target lesion revascularization)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: The Constant Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Disease Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Control Measuring Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neovascularization of the carotid plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: CTC-AXL measurement concordance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean inter-dialytic weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Device Related Serious Adverse events at 6 months post operation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of cases with Fully and successfully implanted device at the end of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of clients screened for prenatal alcohol exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of clients diagnosed with a fetal alcohol spectrum disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Provider FASD-Informed Care Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Renal affection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Persistent Abnormal Neuropathic Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NeoBAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in 24-hour systolic ABPM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemodynamic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Psychophysiological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterization of immune cell infiltrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects with adverse reactions of grade 3 or higher according to CTCAE 5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of therapy discontinuations due to adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: 28-day efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observation-based movement analyses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of intestinal parasitic infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Modified shuttle walk test (MST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Recidivism
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Index of Microcirculatory Resistance (IMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of oxygen and carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vascular circulation measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of Upper Respiratory Symptomatic Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Upper Respiratory Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of Upper Respiratory Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: resting state fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Morphological MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial Spin Labelling MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete metabolic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acceptability of at-home ration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of test dose
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: isokinetic hamstring eccentric peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 30m sprint performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experience a Treatment Emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: International Consultation on Incontinence Questionnaire- Short Form (ICIQ-SF) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: International Index of Erectile Function-15 (IIEF-15) Score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Amplitude of intrinsic hand muscle response to single-pulse transcranial magnetic stimulation (TMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hand dexterity on the nine-hole peg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Facial Wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep Quality Scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Solicited local adverse events post-vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited systemic adverse events post-vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the SMART IPL system
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in Oral Tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24h ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean ablation energy needed to ablate stone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MIH prevalence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to complete a course of the ketogenic diet
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Identification of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Thiol-disulfide level in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal nerve fiber thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with more abnormalities detected by OGM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants initiating HCV treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of BI - Bleeding Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of GI - Gingival Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of PCR - Plaque Control Record
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-kala-azar-dermal leishmaniasis (PKDL)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of VL relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients using oncology support services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Subjective level of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of pain at palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural consequences of control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Behavioral consequences of control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vital sign abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Pulse Pressure Variation (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral mucositis prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osteonecrosis of the jaws prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral mucositis treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osteonecrosis of the jaws treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craniocervical flexion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GLOBAL RATING OF CHANGE SCALE (GROC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sensitivity and specificity of palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three Dimensional Difference Between Impressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Hepatic Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Number of LGBTQ community stakeholders participating in interviews/focus groups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of patient navigation and smoking cessation interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with navigator throughout navigation and smoking cessation interventions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of study procedures and intervention: eligibility and recruitment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptability of study procedures and intervention: attrition
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Determining the success of our randomization procedures: as per protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Vitamin A liver reserves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neck disability scale changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in colonoscopy performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Systemic inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hanson Sex Attitude Questionnaire (HSAQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Victim Empathy Distortion Scale (VES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Framingham Risk Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Immunogenicity measured by serum anti-CGRP antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: New-onset hyperthyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: New-onset anti-throid drug treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total Recovery of the Administered Radiolabelled Drug-related Material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-infinity: Area Under the Plasma Concentration Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of distal sodium reabsorption (ADRNa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical success rate after ceftazidime-avibactam treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiologic success rate after ceftazidime-avibactam treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Knee Documentation Committee 2000
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Oxford Score (OS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Identification of Volatile Organic Compounds related to Colorectal malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulative incidence of WHO clinical Stage 3 or Stage 4 conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of medical conditions that required hospitalization, resulted in persistent or significant disability or incapacity, were life threatening, or resulted in death
Endpoint domain: Adverse events/effects
Primary endpoint: concentration of gingival crevicular fluid (GCF) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentration of serum parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative cognitive decline (POCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUCt of CKD-348(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CKD-348(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft Take
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite of CV death or first hospitalization due to HF
Endpoint domain: Mortality/survival
Primary endpoint: Detection of inflammatory plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional myocardial replacement fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome
Endpoint domain: Mortality/survival
Primary endpoint: AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome
Endpoint domain: Mortality/survival
Primary endpoint: F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Blood-oxygen-level dependent (BOLD) signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Procedural Safety
Endpoint domain: Adverse events/effects